The Influence of Valproic Acid Treatment on Hair and Serum Zinc Levels and Serum Biotinidase Activity

    Yakup Yılmaz, Haydar Ali Taşdemir, Muhammet Şükrü Paksu
    Studysummary This study found that pediatric patients on valproic acid may experience hair loss due to reduced zinc and biotinidase levels within the first 3 months, with zinc depletion continuing to contribute by the 6th month.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ejpn-journal.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Serum and Liver Tissue Biotinidase Enzyme Activity in Rats Administered Valproic Acid Brain & development · 2006
    2. Low Serum Biotinidase Activity in Children with Valproic Acid Monotherapy Epilepsia · 2001
    3. Valproic Acid Teratogenicity in Whole Embryo Culture Is Not Prevented by Zinc Supplementation Biochemical Pharmacology · 1986